PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $232,587 | +61.5% | 6,024 | +122.3% | 0.03% | -28.3% |
Q3 2022 | $144,000 | -99.9% | 2,710 | +3.7% | 0.05% | -9.8% |
Q2 2022 | $152,338,000 | +85483.1% | 2,613 | +12.0% | 0.05% | +6.2% |
Q1 2022 | $178,000 | +147.2% | 2,333 | +80.7% | 0.05% | +84.6% |
Q3 2021 | $72,000 | +80.0% | 1,291 | +97.7% | 0.03% | +73.3% |
Q2 2021 | $40,000 | – | 653 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |